Identification of novel biomarkers of hepatocellular carcinoma by high‐definition mass spectrometry: Ultrahigh‐performance liquid chromatography quadrupole time‐of‐flight mass spectrometry and desorption electrospray ionization mass spectrometry imaging

RATIONALE: Hepatocellular carcinoma (HCC) is a highly malignant disease for which the development of prospective or prognostic biomarkers is urgently required. Although metabolomics is widely used for biomarker discovery, there are some bottlenecks regarding the comprehensiveness of detected feature...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagai, Koshi, Uranbileg, Baasanjav, Chen, Zhen, Fujioka, Amane, Yamazaki, Takahiro, Matsumoto, Yotaro, Tsukamoto, Hiroki, Ikeda, Hitoshi, Yatomi, Yutaka, Chiba, Hitoshi, Hui, Shu‐Ping, Nakazawa, Toru, Saito, Ritsumi, Koshiba, Seizo, Aoki, Junken, Saigusa, Daisuke, Tomioka, Yoshihisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Mass Spectrometry for Clinical Diagnosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154627/
https://www.ncbi.nlm.nih.gov/pubmed/31412144
http://dx.doi.org/10.1002/rcm.8551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154627/
https://www.ncbi.nlm.nih.gov/pubmed/31412144
http://dx.doi.org/10.1002/rcm.8551

Ejemplares similares